Long-term safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccine regimen: a cohort study of previously vaccinated adults and children in Sierra Leone (the EBOVAC-Salone extension study)

https://www.thelancet.com/journals/lanafr/home?dgcid=hubspot_update_feature_lanafrlaunch_lanplh&utm_campaign=update-lanplh&utm_medium=email&_hsenc=p2ANqtz--i510ihPM57HS3F15a4nBHxE2X98FywawlEnTNAA4h_yFHyp7s2949ya_FfHuUckp3Mg7NUnCIcKlvcOiO9u8zilCUxA&_hsmi=411606699&utm_content=411556560&utm_source=hs_email Editorial Amplifying African voices to lead science for better health The Lancet Regional Health – Africa https://www.thelancet.com/issue/S3050-5011(26)X2001-6